Clinical Trials in Baltimore

Showing 7661-7680 of 17,842 trials

Evaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants

NCT02256631

The purpose of this study was to assess the safety and pharmacokinetics (PK) of three monoclonal antibodies, VRC01, VRC01LS, and VRC07-523LS, in HIV-exposed infants who are at increased risk of mother-to-child HIV transmission.

HIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)83 participantsStarted Jun 2015

Los Angeles, California, United States • Aurora, Colorado, United States • Fort Lauderdale, Florida, United States +11 more locations

COMPLETEDPhase 3< 1 mile

Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Metastatic Non-squamous NSCLC

NCT01673867

The purpose of the study is to compare the overall survival of BMS-936558 (Nivolumab) as compared with Docetaxel in subjects with non-squamous cell non-small cell lung cancer (NSCLC) after failure of prior platinum-based chemotherapy

Non-Squamous Cell Non-small Cell Lung Cancer

Bristol-Myers Squibb582 participantsStarted Nov 2012

Scottsdale, Arizona, United States • Duarte, California, United States • San Diego, California, United States +116 more locations

Evaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants

Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Metastatic Non-squamous NSCLC

Find Trials by Condition in Baltimore

A Study of Lu AG06466 for the Treatment of Spasticity in Participants With Multiple Sclerosis

Breast Cup Immobilization Device II (GCC 1047)

A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recent-onset Diagnosed Type 1 Diabetes (T1D)

Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS)

SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence

Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Metastatic Breast Cancer

PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement

Ultrasound for Scoliosis Diagnostic Evaluation

Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder

Improving Quality by Maintaining Accurate Problems in the EHR

Sargramostim Use in COVID-19 to Recover Patient Health

Validation of a Salivary miRNA Diagnostic Test for ASD

A Performance Evaluation Study of Arquer's MCM5 Elisa Test (ADXBLADDER) to Aid in the Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer

Olanzapine in OUD Patients

Characterization & Treatment of Chronic Pain After Moderate to Severe TBI

Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19

Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex

A Study of Fitusiran in Severe Hemophilia A and B Patients Previously Receiving Factor or Bypassing Agent Prophylaxis